Evidence map›Paper›PMID 27298625›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2016

Preliminary Screening of Antioxidant and Antibacterial Activities and Establishment of an Efficient Callus Induction in Curculigo latifolia Dryand (Lemba).

Reza Farzinebrahimi, Rosna Mat Taha, Kamaludin A Rashid, Bakrudeen Ali Ahmed, Mahmoud Danaee, Shahril Efzueni Rozali

Abstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Reza FarzinebrahimiInstitute of Biological Sciences (IBS), Faculty of Science, University of Malaya, 50603 Kuala Lumpur, Malaysia.
Rosna Mat TahaInstitute of Biological Sciences (IBS), Faculty of Science, University of Malaya, 50603 Kuala Lumpur, Malaysia.
Kamaludin A RashidBiology Division, Center for Foundation Studies in Science, University of Malaya, 50603 Kuala Lumpur, Malaysia.
Bakrudeen Ali AhmedInstitute of Biological Sciences (IBS), Faculty of Science, University of Malaya, 50603 Kuala Lumpur, Malaysia.
Mahmoud DanaeeAcademic Development Centre (AdeC), Wisma R&D, University of Malaya, 59990 Kuala Lumpur, Malaysia.
Shahril Efzueni RozaliBiology Division, Center for Foundation Studies in Science, University of Malaya, 50603 Kuala Lumpur, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leaf, seed, and tuber explants of C. latifolia were inoculated on MS medium supplemented with various concentrations of BAP and IBA, alone or in combinations, to achieve in vitro plant regeneration. Subsequently, antioxidant and antibacterial activities were determined from in vitro and in vivo plant developed. No response was observed from seed culture on MS media with various concentrations of PGRs. The highest percentage of callus was observed on tuber explants (94%) and leaf explants (89%) when cultured on MS media supplemented with IBA in combination with BAP. A maximum of 88% shoots per tuber explant, with a mean number of shoots (8.8 ± 1.0), were obtained on MS medium supplemented with combinations of BAP and IBA (2.5 mg L(-1)). The best root induction (92%) and mean number (7.6 ± 0.5) from tuber explants were recorded on 2.5 mg L(-1) IBA alone supplemented to MS medium. The higher antioxidant content (80%) was observed from in vivo tuber. However, tuber part from the intact plant showed higher inhibition zone in antibacterial activity compared to other in vitro and in vivo tested parts.

Identifiers

PMID27298625
PMCPMC4889832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.